tp21 is your managing partner for your interdisciplinary research project, your multi-center clinical trial or your technology transfer plans.
20 years tp21 - thanks to all our collaboration partners
The Human Brain Project shows their work at the German Parliament Bundestag. The Virtual Brain is a central part of the exhibition.
Meet Dr. Petra Ritter during the opening event on Nov 27th . Dr. Ritter will also lead a guided tour through the exhibition on Nov 28.
Access to the exhibition is only possible after prior registration via the website.
This exhibition is in partnership with The Human Brain Project, and includes many beautiful exhibits about the brain. You don't want to miss it.
More information about the program >here<.
NISCI (Nogo-A Inhibition in acute Spinal Cord Injury)
is a multicenter, multinational, placebo controlled phase-II study for the safety and preliminary efficacy of intrathecal anti-Nogo-A [NG101] in patients with acute cervical spinal cord injury.
The purpose of the NISCI trial is to test if an antibody therapy can improve motor function and quality of life of tetraplegic patients. A previous trial showed this treatment is safe and well accepted. This current trial has been approved by the National Ethics Committee and Ministry of Health for all participating trial sites.
Find NISCI under Clinical Trials.gov